After hiving off its non-oncology drugs business last year, the Dabur group recently divested its entire stake in Dabur Pharma to Fresenius Kabi, a 100 per cent subsidiary of the Germany-based......
India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that......
Import alert on Ranbaxy’s Mohali unit; Strides’ injectible arm gets warning letter Indian drug makers have again come under the scrutiny of the US Food and Drug Administration (US FDA),......